There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening The investigational drug is an engineered ...

Herpes is a common virus that is getting a rebrand from University of Southern California researchers who are using it to treat stubborn advanced cancer. Herpes has been called “the gift that keeps on ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

According to an international study a new treatment for advanced skin cancer almost doubles survival times. Researchers say 132 patients in the U.S. and Australia who were given the drug vemurafenib ...

The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Schweiger Dermatology Group, one of the nation's fastest-growing and most comprehensive dermatology practices, today announced a landmark year of accelerated ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had ...

The most common treatments for skin cancer on the nose include surgery, radiation, and topical chemotherapy. Mohs surgery has the lowest rate of cancer recurrence among treatment options for skin ...

SCOTTSDALE, Ariz. — May 20, 2025 — A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a ...

Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...